Azithromycin Dispersible Tablets

Azithromycin inhibits bacterial protein synthesis by hindering bacterial transpeptidation. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria: Staphylococcus aureus, Streptococcus pyogenes (Group A B hemolytic streptococci), Pneumococcus, β-hemolytic Streptococcus (grass viridans streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and methicillin-resistant Staphylococcus aureus strains. For other details, please refer to the instructions.

Azithromycin

1. Acute pharyngitis and acute tonsillitis caused by Streptococcus pyogenes. 2. Sinusitis, acute otitis media, acute bronchitis, and acute exacerbation of chronic bronchitis caused by sensitive bacteria. 3. Pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae. 4. Urethritis and cervicitis caused by Chlamydia trachomatis and non-multi-drug resistant Neisseria gonorrhoeae. 5. Skin and soft tissue infections caused by sensitive bacteria.

2 tablets/day

Patients tolerate azithromycin dispersible tablets well, with a low incidence of adverse reactions, and about 0.3% of patients discontinue treatment due to adverse reactions. Gastrointestinal reactions account for the majority of adverse reactions, with the main symptoms including diarrhea (loose stools), upper abdominal discomfort (pain or cramps), nausea, vomiting, and occasional abdominal distension. Generally, they are mild to moderate. Occasionally, reversible increases in liver aminotransferase are seen, with an incidence similar to that of other macrolide antibiotics and penicillins. Transient mild neutropenia has been seen, but whether it is related to azithromycin has not been confirmed.

It is contraindicated in patients who are allergic to azithromycin or any other macrolide drug.

Precautions for children: Pediatric dosage: 1. For the treatment of otitis media and pneumonia, take 10 mg/kg of body weight at once on the first day (maximum daily dose not exceeding 0.5 g), and take 5 mg/kg of body weight at once daily on the second to fifth days (maximum daily dose not exceeding 0.25 g). 2. For the treatment of pediatric pharyngitis and tonsillitis, take 12 mg/kg of body weight at once daily (maximum daily dose not exceeding 0.5 g) for 5 consecutive days. Precautions for pregnancy and lactation: Animal reproductive studies have shown that azithromycin crosses the placenta, but there is no sign of damage to the fetus. There is no data on the secretion of this product in breast milk. The safety of use in pregnant and lactating women has not been confirmed so far, so this product should only be used when there is no appropriate choice for pregnant or lactating women.

1. It is not suitable to be taken at the same time with antacids containing aluminum or magnesium, as the latter can reduce the peak blood concentration of this product by 30%, but there is no effect on the total bioavailability; if it must be used together, azithromycin dispersible tablets should be given 1 hour before or 2 hours after taking the above drugs. 2. When used in combination with theophylline, the concentration of the latter in plasma can be increased, and the plasma theophylline level should be carefully tested. 3. When azithromycin dispersible tablets are used in combination with warfarin, the prothrombin time should be checked. For other details, please refer to the instructions.

normal temperature

0.25g*7 tablets/box

Qionglai Tianyin Pharmaceutical Co., Ltd.

• Founded in:

  2014-11-03

• Address:

  No. 17, Taiziyuan Road, Linqiong Industrial Park, Qionglai City, Sichuan Province

• Tax NO.:

  91510183394485484T

• Registered Funds:

  203 million yuan

• Email:

  Log in to view